ARTV
Artiva Biotherapeutics, Inc.$11.27+0.18 (+1.62%)Prev Close$11.09·MCap$231.1M·P/E—·Vol175.1K·Yield—
▲
Buys (12M)
10
$109.18M
▼
Sells (12M)
18
$915.1K
◆
Net Activity
Net Buyer
$108.26M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Artiva Biotherapeutics, Inc. (ARTV) has been dominated by buying, with 10 insider purchases totaling $109.18M and 18 insider sales totaling $915.1K. The most recent insider transaction was by Banerjee Subhashis (officer: Chief Medical Officer), who sold $98.7K worth of shares on Aug 31, 2026. Artiva Biotherapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $231.1M.
ARTV Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Banerjee Subhashis | officer: Chief Medical Officer | Sell | 8,222 | $12.01 | $98.7K | 142,047 |
| Aug 19, 2026 | Banerjee Subhashis | officer: Chief Medical Officer | Sell | 429 | $12.00 | $5.1K | 144,963 |
| Jul 31, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 45,768 | $9.96 | $455.7K | 17,329,570 |
| Jul 28, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 41,319 | $9.99 | $412.8K | 17,283,802 |
| Jul 23, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 271,108 | $9.74 | $2.64M1.1% OS | 17,242,484 |
| Jul 20, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 160,354 | $8.93 | $1.43M0.6% OS | 16,977,928 |
| Jul 14, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 21,654 | $8.96 | $194.0K | 16,817,572 |
| Jun 29, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 32,876 | $8.89 | $292.1K | 16,795,920 |
| Jun 16, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 531,326 | $8.66 | $4.60M2.1% OS | 16,763,043 |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 1,027,722 | $7.44 | $7.65M4.2% OS | 16,231,717 |
| May 28, 2026 | GC Corp. | 10 percent owner | Buy | 1,432,291 | $11.52 | $16.50M5.8% OS | 4,391,969+48% |
| May 19, 2026 | Raymon Heather | officer: SVP, Research and Development | Sell | 3,095 | $9.01 | $27.9K | 148,228 |
| May 19, 2026 | Aslan Fred | director, officer: Chief Executive Officer | Sell | 27,116 | $9.01 | $244.3K | 1,535,082 |
| May 19, 2026 | Banerjee Subhashis | officer: Chief Medical Officer | Sell | 7,037 | $9.01 | $63.4K | 144,963 |
| May 19, 2026 | Horan Christopher | officer: Chief Tech Operations Officer | Sell | 7,002 | $9.01 | $63.1K | 293,450 |
| May 19, 2026 | Bush Jennifer | officer: COO, CLO, Compliance Officer | Sell | 8,790 | $9.01 | $79.2K | 337,920 |
| May 13, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 6,510,416 | $11.52 | $75.00M26.3% OS | 15,203,995+75% |
| Feb 15, 2026 | Aslan Fred | President and CEO | Sell | 14,600 | $4.00 | $58.4K | 0 |
| Feb 15, 2026 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Sell | 3,515 | $4.00 | $14.1K | 0 |
| Feb 15, 2026 | Horan Christopher | Chief Tech Operations Officer | Sell | 2,187 | $4.00 | $8.7K | 0 |
| Feb 15, 2026 | Raymon Heather | SVP, Research and Development | Sell | 1,521 | $4.00 | $6.1K | 0 |
| Dec 15, 2025 | Aslan Fred | President and CEO | Sell | 3,187 | $6.00 | $19.1K | 0 |
| Nov 15, 2025 | Aslan Fred | President and CEO | Sell | 12,722 | $3.31 | $42.1K | 0 |
| Nov 15, 2025 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Sell | 3,055 | $3.25 | $9.9K | 0 |
| Nov 15, 2025 | Horan Christopher | Chief Tech Operations Officer | Sell | 1,899 | $3.25 | $6.2K | 0 |
| Nov 15, 2025 | Krishnamohan Neha | Chief Financial Officer | Sell | 3,490 | $3.25 | $11.3K | 0 |
| Nov 15, 2025 | Raymon Heather | SVP, Research and Development | Sell | 1,375 | $3.25 | $4.5K | 0 |
| Oct 17, 2025 | Aslan Fred | President and CEO | Sell | 25,500 | $6.00 | $153.0K | 0 |
| May 15, 2025 | Aslan Fred | President and CEO | Sell | 34,444 | $2.65 | $91.4K | 0 |
| May 15, 2025 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Sell | 8,346 | $2.61 | $21.8K | 0 |
| May 15, 2025 | Horan Christopher | Chief Tech Operations Officer | Sell | 3,577 | $2.75 | $9.8K | 0 |
| May 15, 2025 | Krishnamohan Neha | Chief Financial Officer | Sell | 7,154 | $2.63 | $18.8K | 0 |
| May 15, 2025 | Raymon Heather | SVP, Research and Development | Sell | 2,384 | $2.56 | $6.1K | 0 |
| Jul 22, 2024 | Huh Yong-Jun | Director | Buy | 2,083,332 | $12.00 | $25.00M8.4% OS | 0 |
ARTV Insider Buying Activity
The following table shows recent insider purchases of Artiva Biotherapeutics, Inc. (ARTV) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 45,768 | $9.96 | $455.7K | 17,329,570 |
| Jul 28, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 41,319 | $9.99 | $412.8K | 17,283,802 |
| Jul 23, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 271,108 | $9.74 | $2.64M1.1% OS | 17,242,484 |
| Jul 20, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 160,354 | $8.93 | $1.43M0.6% OS | 16,977,928 |
| Jul 14, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 21,654 | $8.96 | $194.0K | 16,817,572 |
| Jun 29, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 32,876 | $8.89 | $292.1K | 16,795,920 |
| Jun 16, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 531,326 | $8.66 | $4.60M2.1% OS | 16,763,043 |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 1,027,722 | $7.44 | $7.65M4.2% OS | 16,231,717 |
| May 28, 2026 | GC Corp. | 10 percent owner | Buy | 1,432,291 | $11.52 | $16.50M5.8% OS | 4,391,969+48% |
| May 13, 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 6,510,416 | $11.52 | $75.00M26.3% OS | 15,203,995+75% |
| Jul 22, 2024 | Huh Yong-Jun | Director | Buy | 2,083,332 | $12.00 | $25.00M8.4% OS | 0 |
ARTV Insider Selling Activity
The following table shows recent insider sales of Artiva Biotherapeutics, Inc. (ARTV) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Banerjee Subhashis | officer: Chief Medical Officer | Sell | 8,222 | $12.01 | $98.7K | 142,047 |
| Aug 19, 2026 | Banerjee Subhashis | officer: Chief Medical Officer | Sell | 429 | $12.00 | $5.1K | 144,963 |
| May 19, 2026 | Raymon Heather | officer: SVP, Research and Development | Sell | 3,095 | $9.01 | $27.9K | 148,228 |
| May 19, 2026 | Aslan Fred | director, officer: Chief Executive Officer | Sell | 27,116 | $9.01 | $244.3K | 1,535,082 |
| May 19, 2026 | Banerjee Subhashis | officer: Chief Medical Officer | Sell | 7,037 | $9.01 | $63.4K | 144,963 |
| May 19, 2026 | Horan Christopher | officer: Chief Tech Operations Officer | Sell | 7,002 | $9.01 | $63.1K | 293,450 |
| May 19, 2026 | Bush Jennifer | officer: COO, CLO, Compliance Officer | Sell | 8,790 | $9.01 | $79.2K | 337,920 |
| Feb 15, 2026 | Aslan Fred | President and CEO | Sell | 14,600 | $4.00 | $58.4K | 0 |
| Feb 15, 2026 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Sell | 3,515 | $4.00 | $14.1K | 0 |
| Feb 15, 2026 | Horan Christopher | Chief Tech Operations Officer | Sell | 2,187 | $4.00 | $8.7K | 0 |
| Feb 15, 2026 | Raymon Heather | SVP, Research and Development | Sell | 1,521 | $4.00 | $6.1K | 0 |
| Dec 15, 2025 | Aslan Fred | President and CEO | Sell | 3,187 | $6.00 | $19.1K | 0 |
| Nov 15, 2025 | Aslan Fred | President and CEO | Sell | 12,722 | $3.31 | $42.1K | 0 |
| Nov 15, 2025 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Sell | 3,055 | $3.25 | $9.9K | 0 |
| Nov 15, 2025 | Horan Christopher | Chief Tech Operations Officer | Sell | 1,899 | $3.25 | $6.2K | 0 |
| Nov 15, 2025 | Krishnamohan Neha | Chief Financial Officer | Sell | 3,490 | $3.25 | $11.3K | 0 |
| Nov 15, 2025 | Raymon Heather | SVP, Research and Development | Sell | 1,375 | $3.25 | $4.5K | 0 |
| Oct 17, 2025 | Aslan Fred | President and CEO | Sell | 25,500 | $6.00 | $153.0K | 0 |
| May 15, 2025 | Aslan Fred | President and CEO | Sell | 34,444 | $2.65 | $91.4K | 0 |
| May 15, 2025 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Sell | 8,346 | $2.61 | $21.8K | 0 |
| May 15, 2025 | Horan Christopher | Chief Tech Operations Officer | Sell | 3,577 | $2.75 | $9.8K | 0 |
| May 15, 2025 | Krishnamohan Neha | Chief Financial Officer | Sell | 7,154 | $2.63 | $18.8K | 0 |
| May 15, 2025 | Raymon Heather | SVP, Research and Development | Sell | 2,384 | $2.56 | $6.1K | 0 |
ARTV Insiders
Similar Stocks to ARTV
VRTX
Vertex Pharmaceuticals Incorporated
$543.89+0.38%
$138.98B
REGN
Regeneron Pharmaceuticals, Inc.
$800.55+0.77%
$85.35B
MRNA
Moderna, Inc.
$138.41+0.30%
$56.65B
RVMD
Revolution Medicines, Inc.
$204.55-1.64%
$44.98B
ALNY
Alnylam Pharmaceuticals, Inc.
$241.00+1.56%
$31.58B
INSM
Insmed Incorporated
$121.78+2.73%
$26.31B
INCY
Incyte Corporation
$123.54-0.73%
$25.89B
UTHR
United Therapeutics Corporation
$511.43-0.82%
$22.41B